Patent ID: 6294517
Filing Date: 2001-09-25
Classification: A61K,A61P,C07C,C07D,Y10S

Abstract:
A composition comprising an alkaloid selected from the group consisting of rauwolscine, corynanthine, yohimbine, apoyohimbine, .alpha.-yohimbine, yohimbol, pseudoyohimbine, and epi-3.alpha.-yohimbine, and a compound that donates, transfers or releases nitric oxide, elevates endogenous levels of endothelium-derived relaxing factor, or stimulates nitric oxide synthesis selected from the group consisting of S-nitroso-N-acetylcysteine, S-nitroso-captopril, S-nitroso-homocysteine, S-nitroso-cysteine, S-nitroso-glutathione, and L-arginine, in an amount effective to treat human impotence.